Physician profile
Joy Liu
NPI 1912128547
$4,485.72
in general payments reported to CMS, 2019-2025
37 companies · $684 in 2025
The $684 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $557 · 2020: $476 · 2021: $604 · 2022: $587 · 2023: $712 · 2024: $866 · 2025: $684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,262.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $485.77 | 2020-2025 | |
| Glaxosmithkline, LLC. | $465.98 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Pfizer INC. | $453.10 | 2019-2025 | |
| Novo Nordisk INC | $359.08 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $334.29 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Astrazeneca Pharmaceuticals LP | $314.18 | 2019-2025 | Airsupra, Farxiga, Tagrisso |
| Amgen INC. | $248.31 | 2019-2025 | Evenity, Prolia, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $219.52 | 2019-2025 | Jardiance |
| Radius Health, INC. | $163.76 | 2019-2023 | Tymlos |
| Exact Sciences Corporation | $127.08 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novartis Pharmaceuticals Corporation | $114.88 | 2022-2025 | |
| Kowa Pharmaceuticals America, INC. | $109.71 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $108.02 | 2021-2025 | Strensiq |
| Hologic Sales and Service, LLC | $102.55 | 2020-2025 | Aptima |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $87.57 | 2019-2024 | Xifaxan |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $83.71 | 2019-2021 | |
| Amarin Pharma, INC. | $80.54 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $64.86 | 2023-2024 | Spravato |
| Boston Scientific Corporation | $54.52 | 2019-2025 | General - Pain Management |
| Vanda Pharmaceuticals INC. | $48.11 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $46.98 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $44.01 | 2021 | |
| Baxter Healthcare | $43.28 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Sanofi Pasteur INC. | $35.75 | 2020-2023 | |
| Allergan, INC. | $35.74 | 2019-2020 | |
| Currax Pharmaceuticals LLC | $33.16 | 2024-2025 | Contrave |
| Philips North America LLC | $29.37 | 2021-2024 | (Ak6) Vest Therapy |
| Medtronic, INC. | $26.17 | 2024 | Intellis Adaptivestim |
| Astellas Pharma US INC | $21.69 | 2024 | Veozah |
| Ibsa Pharma INC. | $21.42 | 2021 | |
| Sanofi-Aventis U.S. LLC | $18.86 | 2024 | |
| Vbi Vaccine (Delaware) INC. | $18.48 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $18.46 | 2025 | |
| Corcept Therapeutics | $18.23 | 2025 | Korlym |
| Ironwood Pharmaceuticals, INC | $17.87 | 2021 | |
| Hologic INC | $16.13 | 2021 | |
| Nevro Corp. | $14.58 | 2023 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joy Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.